To know the efficacy of two unani formulations in deranged lipid levels

Not Applicable

• Conditions: Health Condition 1: E785- Hyperlipidemia, unspecified

• Registration Number: CTRI/2022/09/045383
• Lead Sponsor: Department of moalajat Ajmal khan Tibbiya college Aligarh Muslim university Aligarh

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

A) Patients between 30-60 years of age, both male and female

B) Patient ready to participate in the study and ready to follow the instructions

Subjective criteria:

a) Increased body weight

b) Dyspnea on exertion

c) Fatigue

d) Xanthelasma

e) Xanthoma

f) Corneal arcus

Objective criteria

Lipid profile:

Serum cholesterol: 200-300mg/dl Serum triglycerides: 200-300mg/dl Serum HDL: 30-50 mg/dl Serum LDL: 100-150 mg/dl Serum VLDL: 30-50 mg/dl BMI: 25-30kg/m2

Exclusion Criteria

A) Pregnacy and lactation

B) Diabetic patient having HBAlc >8 % and FBS >250 mg /dl

C) Diabetes mellitus with complications like Diabetic ketoacidosis, retinopathy, Nephropathy, CHD, CVD etc

D) Several liver and renal diseases E) Severe systemic illnesses

F) Patient who failed to follow up.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in following objective criteria <br/ ><br> Lipid profile: <br/ ><br>Serum cholesterol:200-300mg/dl Serum triglycerides:200-300mg/dl <br/ ><br>Serum HDL: 30-50 mg/dl Serum LDL: 100-150 mg/dl Serum VLDL: 30-50 mg/dl <br/ ><br> BMI: <br/ ><br> 25-30kg/m2Timepoint: Three months with fortnightly follow-up

Secondary Outcome Measures

Name	Time	Method
Improvement in subjective criteria such as <br/ ><br>Dyspea <br/ ><br>Xanthoma <br/ ><br>Xanthelasma <br/ ><br>Corneal arcus <br/ ><br>Timepoint: Three months with fortnighly follwup